Ignite Creation Date:
2025-12-25 @ 12:24 AM
Ignite Modification Date:
2025-12-25 @ 10:29 PM
Study NCT ID:
NCT01915758
Status:
COMPLETED
Last Update Posted:
2017-07-18
First Post:
2012-10-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-11-21
Start Date Type:
ACTUAL
Primary Completion Date:
2009-02-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-02-20
Completion Date Type:
ACTUAL
First Submit Date:
2012-10-11
First Submit QC Date:
None
Study First Post Date:
2013-08-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-13
Last Update Post Date:
2017-07-18
Last Update Post Date Type:
ACTUAL